Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma Operating Income 2006-2019 | PDLI

PDL BioPharma operating income from 2006 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  
PDL BioPharma Annual Operating Income
(Millions of US $)
2018 $-51
2017 $194
2016 $129
2015 $550
2014 $546
2013 $427
2012 $355
2011 $344
2010 $211
2009 $297
2008 $243
2007 $184
2006 $155
2005 $-49
PDL BioPharma Quarterly Operating Income
(Millions of US $)
Q3 2019 $9
Q2 2019 $-50
Q1 2019 $10
Q4 2018 $33
Q3 2018 $37
Q2 2018 $-125
Q1 2018 $4
Q4 2017 $30
Q3 2017 $33
Q2 2017 $113
Q1 2017 $19
Q4 2016 $-8
Q3 2016 $33
Q2 2016 $11
Q1 2016 $93
Q4 2015 $162
Q3 2015 $116
Q2 2015 $131
Q1 2015 $142
Q4 2014 $99
Q3 2014 $159
Q2 2014 $156
Q1 2014 $132
Q4 2013 $108
Q3 2013 $92
Q2 2013 $142
Q1 2013 $85
Q4 2012 $85
Q3 2012 $80
Q2 2012 $121
Q1 2012 $70
Q4 2011 $68
Q3 2011 $80
Q2 2011 $118
Q1 2011 $78
Q4 2010 $-28
Q3 2010 $75
Q2 2010 $112
Q1 2010 $53
Q4 2009 $53
Q3 2009 $66
Q2 2009 $120
Q1 2009 $58
Q4 2008 $53
Q3 2008 $57
Q2 2008 $96
Q1 2008 $37
Q4 2007 $-25
Q3 2007 $-8
Q2 2007 $10
Q1 2007 $-1
Q4 2006 $-4
Q3 2006 $-8
Q2 2006 $-8
Q1 2006 $-27
Q4 2005 $-35
Q3 2005 $-43
Q2 2005 $-3
Q1 2005 $-85
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.375B $0.198B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.901B 16.46
CSL (CSLLY) Australia $94.668B 0.00
Gilead Sciences (GILD) United States $79.957B 9.91
Vertex Pharmaceuticals (VRTX) United States $60.559B 61.81
Biogen (BIIB) United States $51.632B 8.86
Illumina (ILMN) United States $47.916B 52.57
Regeneron Pharmaceuticals (REGN) United States $42.333B 18.54
Alexion Pharmaceuticals (ALXN) United States $24.897B 12.30
Seattle Genetics (SGEN) United States $18.451B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.365B 40.31
BioMarin Pharmaceutical (BMRN) United States $16.010B 0.00
Genmab (GNMSF) Denmark $14.044B 62.03
Alnylam Pharmaceuticals (ALNY) United States $13.305B 0.00
Galapagos (GLPG) Belgium $12.398B 31.94
Exact Sciences (EXAS) United States $11.656B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.384B 54.64
BeiGene (BGNE) Cayman Islands $10.251B 0.00
Sarepta Therapeutics (SRPT) United States $9.713B 0.00
Bio-Techne Corp (TECH) United States $8.362B 55.97
Guardant Health (GH) United States $7.827B 0.00
QIAGEN (QGEN) Netherlands $7.710B 25.14
BioNTech SE (BNTX) Germany $7.297B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.172B 18.23
Amarin (AMRN) Ireland $7.166B 0.00
Moderna (MRNA) United States $7.002B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.863B 0.00
Reata Pharmaceuticals (RETA) United States $6.547B 0.00
Exelixis (EXEL) United States $6.211B 17.47
Ascendis Pharma (ASND) Denmark $5.919B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.718B 0.00
Bluebird Bio (BLUE) United States $5.393B 0.00
Repligen (RGEN) United States $5.201B 94.25
China Biologic Products (CBPO) China $4.606B 25.94
MorphoSys AG (MOR) Germany $4.252B 0.00
Blueprint Medicines (BPMC) United States $3.983B 0.00
Mirati Therapeutics (MRTX) United States $3.842B 0.00
Immunomedics (IMMU) United States $3.741B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.609B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.517B 0.00
MyoKardia (MYOK) United States $3.475B 0.00
NeoGenomics (NEO) United States $3.404B 181.11
Adaptive Biotechnologies (ADPT) United States $3.403B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.292B 0.00
Alkermes (ALKS) Ireland $3.149B 0.00
Zai Lab (ZLAB) China $3.002B 0.00
Acceleron Pharma (XLRN) United States $2.986B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.978B 0.00
Halozyme Therapeutics (HALO) United States $2.950B 0.00
Genmab (GMAB) Denmark $2.938B 6.05
UniQure (QURE) Netherlands $2.907B 0.00
Emergent Biosolutions (EBS) United States $2.893B 28.74
Amicus Therapeutics (FOLD) United States $2.691B 0.00
Epizyme (EPZM) United States $2.326B 0.00
Arena Pharmaceuticals (ARNA) United States $2.319B 5.39
RA PHARMCTL INC (RARX) United States $2.217B 0.00
Myriad Genetics (MYGN) United States $2.151B 31.78
Denali Therapeutics (DNLI) United States $2.123B 0.00
Insmed (INSM) United States $2.027B 0.00
Principia Biopharma (PRNB) United States $1.879B 0.00
Fate Therapeutics (FATE) United States $1.837B 0.00
REGENXBIO (RGNX) United States $1.807B 0.00
Zymeworks (ZYME) Canada $1.737B 0.00
Arvinas (ARVN) United States $1.731B 0.00
Akcea Therapeutics (AKCA) United States $1.670B 0.00
Editas Medicine (EDIT) United States $1.643B 0.00
Ligand Pharmaceuticals (LGND) United States $1.625B 31.26
Intra-Cellular Therapies (ITCI) United States $1.476B 0.00
Innoviva (INVA) United States $1.470B 4.33
Dicerna Pharmaceuticals (DRNA) United States $1.449B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.424B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.409B 0.00
Coherus BioSciences (CHRS) United States $1.393B 0.00
Alector (ALEC) United States $1.371B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.197B 0.00
DBV Technologies S.A (DBVT) France $1.164B 0.00
Zealand Pharma (ZEAL) Denmark $1.149B 0.00
Codexis (CDXS) United States $1.087B 0.00
Sangamo Therapeutics (SGMO) United States $1.025B 0.00
Revance Therapeutics (RVNC) United States $1.009B 0.00
PHARMA MAR SA (PHMMF) Spain $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.955B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.902B 0.00
Heska (HSKA) United States $0.833B 212.78
Mesoblast (MESO) Australia $0.829B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.825B 6.94
Cellectis S.A (CLLS) France $0.783B 0.00
Vericel (VCEL) United States $0.779B 290.50
GENFIT S.A (GNFT) France $0.777B 0.00
Twist Bioscience (TWST) United States $0.765B 0.00
Adverum Biotechnologies (ADVM) United States $0.756B 0.00
Cytokineticsorporated (CYTK) United States $0.745B 0.00
Intellia Therapeutics (NTLA) United States $0.741B 0.00
ANI Pharmaceuticals (ANIP) United States $0.739B 12.61
Sorrento Therapeutics (SRNE) United States $0.727B 0.00
NantKwest (NK) United States $0.726B 0.00
UROGEN PHARMA (URGN) United States $0.723B 0.00
Retrophin (RTRX) United States $0.717B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Cara Therapeutics (CARA) United States $0.676B 0.00
Anika Therapeutics (ANIK) United States $0.672B 21.81
AC Immune SA (ACIU) Switzerland $0.656B 15.17
Prothena (PRTA) Ireland $0.614B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.581B 0.00
Precision BioSciences (DTIL) United States $0.563B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.541B 0.00
Agenus (AGEN) United States $0.529B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Dynavax Technologies (DVAX) United States $0.517B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.516B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.509B 0.00
Arcus Biosciences (RCUS) United States $0.480B 0.00
Bellus Health (BLU) Canada $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.451B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.451B 3.12
AnaptysBio (ANAB) United States $0.438B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.415B 0.00
Kindred Biosciences (KIN) United States $0.401B 0.00
Pfenex (PFNX) United States $0.397B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
Cue Biopharma (CUE) United States $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
Avid Bioservices (CDMO) United States $0.368B 0.00
Mersana Therapeutics (MRSN) United States $0.364B 0.00
Cel-Sci (CVM) United States $0.353B 0.00
Stemline Therapeutics (STML) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Puma Biotechnology (PBYI) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Cellular Biomedicine (CBMG) United States $0.340B 0.00
Inovio Pharmaceuticals (INO) United States $0.340B 0.00
Albireo Pharma (ALBO) United States $0.329B 0.00
MannKind (MNKD) United States $0.324B 0.00
VBI Vaccines (VBIV) United States $0.317B 0.00
Starpharma Holdings (SPHRY) Australia $0.314B 0.00
Compugen (CGEN) Israel $0.312B 0.00
Geron (GERN) United States $0.290B 0.00
OSMOTICA PHARM (OSMT) United States $0.289B 0.00
IVERIC Bio (ISEE) United States $0.279B 0.00
WAVE Life Sciences (WVE) Singapore $0.278B 0.00
Sutro Biopharma (STRO) United States $0.275B 0.00
ADMA Biologics Inc (ADMA) United States $0.272B 0.00
ChromaDex (CDXC) United States $0.266B 0.00
Kamada (KMDA) Israel $0.262B 7.65
Prometic Life Sciences (LMNL) Canada $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.255B 0.00
Seres Therapeutics (MCRB) United States $0.244B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Affimed (AFMD) Germany $0.226B 0.00
Theratechnologies (THTX) Canada $0.225B 0.00
Cerecor (CERC) United States $0.224B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.223B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.217B 0.00
Exicure (XCUR) United States $0.213B 0.00
XOMA (XOMA) United States $0.209B 0.00
Athersys (ATHX) United States $0.201B 0.00
Fortress Biotech (FBIO) United States $0.199B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Protagonist Therapeutics (PTGX) United States $0.195B 0.00
Arbutus Biopharma (ABUS) Canada $0.189B 0.00
Five Prime Therapeutics (FPRX) United States $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.187B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.185B 0.00
Alcobra (ARCT) United States $0.185B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.184B 0.00
CorMedix Inc (CRMD) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.173B 0.00
TELA Bio (TELA) United States $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Palatin Technologies (PTN) United States $0.167B 4.56
Menlo Therapeutics (MNLO) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Novavax (NVAX) United States $0.154B 0.00
Selecta Biosciences (SELB) United States $0.151B 0.00
Applied Genetic Technologies (AGTC) United States $0.148B 0.00
Verastem (VSTM) United States $0.146B 0.00
Windtree Therapeutics (WINT) United States $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 3.65
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Arsanis (XFOR) United States $0.128B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.126B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.125B 6.43
Aptinyx (APTX) United States $0.121B 0.00
VTv Therapeutics (VTVT) United States $0.119B 0.00
Liquidia Technologies (LQDA) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
OvaScience (MLND) United States $0.111B 0.00
Clearside Biomedical (CLSD) United States $0.110B 0.00
Antibe Therapeutics (ATBPF) Canada $0.109B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.105B 0.00
Acorda Therapeutics (ACOR) United States $0.103B 0.00
Synlogic (SYBX) United States $0.103B 0.00
Proteostasis Therapeutics (PTI) United States $0.099B 0.00
Emmaus Life Sciences (EMMA) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
Trevena (TRVN) United States $0.081B 0.00
Orgenesis (ORGS) United States $0.081B 5.23
Vaccinex (VCNX) United States $0.075B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Curis (CRIS) United States $0.057B 0.00
Idera Pharmaceuticals (IDRA) United States $0.057B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Evogene (EVGN) Israel $0.044B 0.00
Soligenix (SNGX) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Celsion (CLSN) United States $0.037B 0.00
BioCardia (BCDA) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.031B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Unum Therapeutics (UMRX) United States $0.030B 0.00
Novogen (KZIA) Australia $0.029B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Advaxis (ADXS) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
IBio (IBIO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.005B 0.00